Ismoclep - International Society for Molecular and Clinical Epigenetics

18/06/2026

As part of your isMOCLEP membership benefits, we are pleased to offer access to a free professional training opportunity designed to support your scientific and career development. Others are also welcome to join!

Take a moment to explore the workshop offer below and watch the short promotional video to learn more about the programme, its content, and how it can benefit your research and professional growth.

Bisulfite DNA Pyrosequencing Workshop – Hands-On Training in DNA Methylation Analysis

👩‍🔬👨‍🔬We invite scientists, students and laboratory technicians to join us for an intensive 3-day workshop dedicated to DNA methylation analysis using pyrosequencing, with a special focus on circulating cell-free DNA (cfDNA).

🗓️Date: 4-6.11.2026

📍Location: Institute of Human Genetics PAS in Poznań, Poland.

This practical course combines expert lectures with laboratory training, guiding participants through the complete DNA methylation analysis workflow.

🔬 The scientific program also includes lectures on cutting-edge methylome analysis platforms, including:
•⁠ ⁠Illumina 5-base sequencing
•⁠ ⁠Illumina EPIC methylation microarrays
•⁠ ⁠Oxford Nanopore Technologies (ONT) sequencing

🤝Beyond the laboratory, the workshop offers excellent opportunities for networking and scientific exchange through discussion sessions, a city trip, and a get-together event.

📄All participants will receive a certificate confirming the skills acquired during the course.

💶 Participation fee: 100 EUR 🎓Members of isMOCLEP participate free of charge.
👥 Number of participants is limited

More info and registration: https://igcz.poznan.pl/bisulfite-dna-pyrosequencing-workshop/

See you in Poznan!

16/06/2026

Join us on Thursday, June 25, at 4 PM CEST, for our next Drop-in Session!

🗣️Our speaker Prof. Tommy Kaplan (The Hebrew University of Jerusalem) will present:
“A DNA methylation atlas of normal human cell types”

"This talk will discuss how DNA methylation contributes to genome regulation across human cell types, tissues and physiological states. I will present work on whole-genome methylation atlases, cell-type-specific regulatory elements, imprinting and allele-specific methylation, and variation associated with genetics, age and s*x. I will also describe how methylation signatures in circulating cell-free DNA can be used to infer tissue origins and study disease-related cell turnover."

Don’t miss it! 🔥🔥🔥


Want to know more?
Join the meeting!

Not an member? No problem — just let us know at [email protected]

20/05/2026

🎓 Looking for a PhD opportunity in cancer epigenetics?

The lab of Ragnhild Eskeland at CanCell is recruiting a PhD candidate for an exciting project in cancer chromatin biology, epigenetics, and computational epigenomics.

The research will combine multi-omics approaches and bioinformatics to uncover epigenetic mechanisms driving sarcoma development.

This opportunity is ideal for candidates with a background in:
🧬 Molecular Biology
🧪 Biochemistry
💻 Bioinformatics or Biostatistics

Applicants should also have experience with programming (Python, R, or bash) and analysis of high-throughput sequencing data such as RNA-seq.

📍 Oslo, Norway Universitetet i Oslo (UiO)
📅 Application deadline: 22 May 2026

This is an excellent chance to join a leading interdisciplinary research environment and contribute to cutting-edge discoveries in cancer epigenetics.

🔗 Full details and application: Jobbnorge

https://www.jobbnorge.no/en/available-jobs/job/300588/phd-research-fellowship-in-cancer-chromatin-epigenetics-and-computational-epigenomics

Job title: PhD Research Fellowship in Cancer Chromatin, Epigenetics, and Computational Epigenomics  (300588), Employer: University of Oslo, Deadline: Friday, May 22, 2026

19/05/2026

Another outstanding publication from our colleagues in Italy!
In this study, first-authored by Carmela Lara Dell’aversana and co-authored by Giulia Sgueglia and Lucia Altucci , three isMOCLEP members from Università degli Studi della Campania "Luigi Vanvitelli" and Università LUM report the development of UVI5008 — the first reversible, non-covalent BTK epi-inhibitor for B-cell malignancies.
Published in the Journal of Hematology & Oncology, the study highlights a promising new therapeutic strategy for patients with relapsed or refractory chronic lymphocytic leukemia.
Read the publication:
https://lnkd.in/dww2vwuJ

Congratulations to the entire team!

16/05/2026

is increasingly becoming part of the global conversation on the future of medicine.

We are proud to share that Tomasz K. Wojdacz , President of the International Society of Clinical and Molecular Epigenetics (isMOCLEP), opened the oncology-focused session at Impact CEE 2026 in Poznań as a keynote speaker.

His keynote lecture, titled:

“DNA Doesn’t Have the Last Word – How Epigenetics Is Changing Our Approach to Health, Aging and Cancer”

highlighted a fundamental shift in how we understand biology and disease. While genetics provides the blueprint, epigenetics reveals how lifestyle, environment, and aging shape gene activity—offering entirely new possibilities for prevention, diagnosis, and treatment.

Impact CEE is one of the most influential business, technology and innovation events in Central and Eastern Europe. The presence of epigenetics on this stage is a powerful reminder that science is increasingly taking its rightful place at the heart of the most important societal conversations.

This is made possible by individuals who continuously develop future-oriented competencies, recognize emerging opportunities, and have the vision to connect cutting-edge science with real-world challenges. Iwona Szumska-Miękina and the team 💪

At isMOCLEP, we are not slowing down in our mission to bring clinical and molecular epigenetics closer to the broader scientific, medical, business and public communities.

Tomasz concluded his keynote by presenting the strength of our international society and inviting participants to join CLEPIC - CLEPIC-Clinical Epigenetics International Conference - an expanding European platform that connects researchers, clinicians and innovators working to translate epigenetic discoveries into practical applications for medicine.

Congratulations, Tomasz, on this outstanding keynote and for your continued leadership in positioning epigenetics where it belongs: at the forefront of conversations shaping the future of health and medicine.

Pomorski Uniwersytet Medyczny w Szczecinie

15/05/2026

We are delighted to celebrate another publication by members of the isMOCLEP community.
This time, we are proud to highlight a new paper led by Giulia Sgueglia and co-authored by isMOCLEP members, including our co-founder Lucia Altucci and Carmela Dell’Aversana, representing University of Campania Luigi Vanvitelli and Libera Università Mediterranea (LUM).
Their study, published in Cell Death & Disease, reveals how epigenetic regulation of BCLAF1 splicing contributes to acute myeloid leukemia and identifies a promising new therapeutic target.
Congratulations to the entire team on this important contribution to cancer epigenetics.
Explore the data:

PMID: 41872140; DOI:10.1038/s41419-026-08594-4

14/05/2026

Join us on Thursday, May 28, at 4 PM CEST, for our next Drop-in Session!

Our speaker Anne Bozack will present:

“Applications and Novel Development of Epigenetic Biomarkers in Molecular Epidemiology”

Don’t miss it! 🔥🔥🔥



Want to know more?

Join the meeting!

Not an member? No problem — just let us know at [email protected]

08/05/2026

Our Members Publish 📢
Congrats to Sabrina Ruhrmann on another publication in Nature Metabolism.
🔬 Cell-specific DNA methylation in human alpha and beta cells regulates gene expression in type 2 diabetes (2026)
The study reveals extensive DNA methylation changes in pancreatic cells linked to Type 2 Diabetes, many of which impact gene expression and overlap with known risk genes.
📊 Explore the data:
https://alpha-beta-methylome.serve.scilifelab.se/app/alpha-beta-methylome/
📄 Publication available here:
https://www.nature.com/articles/s42255-026-01498-9
👏 Congrats to all authors!

04/05/2026

As the iSMOCLEP Society, we don’t just organize the CLEPIC-Clinical Epigenetics International Conference — we also support other epigenetics-focused events across the community.

Here’s one of them: Epi.Bel 2026 🧬

For more information, check out the flyer!

https://epibelconference.be/

27/04/2026

Quick reminder!
Don`t forget to join our drop-in session !

How can scientists build a strong personal brand? 🔬✨

Join Katarzyna M. Zamaro in a drop-in session on shaping your academic identity and communicating your impact.

📅 Drop-in session: Thu 30 April, 4 PM CEST